|
1
|
Moe AM, Golding AE and Bement WM: Cell
healing: Calcium, repair and regeneration. Semin Cell Dev Biol.
45:18–23. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cui C, Merritt R, Fu L and Pan Z:
Targeting calcium signaling in cancer therapy. Acta Pharm Sin B.
7:1–17. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Tennakoon S, Aggarwal A and Kállay E: The
calcium-sensing receptor and the hallmarks of cancer. Biochim
Biophys Acta. 1863:1398–1407. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Bong AHL and Monteith GR: Calcium
signaling and the therapeutic targeting of cancer cells. Biochim
Biophys Acta Mol Cell Res. 1865:1786–1794. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang QC, Zheng Q, Tan H, Zhang B, Li X,
Yang Y, Yu J, Liu Y, Chai H, Wang X, et al: TMCO1 is an ER Ca(2+)
load-activated Ca(2+) channel. Cell. 165:1454–1466. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Michael Yates T, Ng OH, Offiah AC,
Willoughby J, Berg JN; DDD Study, ; Johnson DS:
Cerebrofaciothoracic dysplasia: Four new patients with a recurrent
TMCO1 pathogenic variant. Am J Med Genet A. 179:43–49. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Kondkar AA, Mousa A, Azad TA, Sultan T,
Alawad A, Altuwaijri S, Al-Obeidan SA and Abu-Amero KK:
Polymorphism rs7555523 in transmembrane and coiled-coil domain 1
(TMCO1) is not a risk factor for primary open angle glaucoma in a
Saudi cohort. J Negat Results Biomed. 15:172016. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li CF, Wu WR, Chan TC, Wang YH, Chen LR,
Wu WJ, Yeh BW, Liang SS and Shiue YL: Transmembrane and coiled-coil
domain 1 impairs the AKT signaling pathway in urinary bladder
urothelial carcinoma: A characterization of a tumor suppressor.
Clin Cancer Res. 23:7650–7663. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhou BO, Nie J, Yang W, Huang C, Huang YE
and Zhao H: Effect of hydrothorax EGFR gene mutation and EGFR-TKI
targeted therapy on advanced non-small cell lung cancer patients.
Oncol Lett. 11:1413–1417. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Pascoe HM, Knipe HC, Pascoe D and Heinze
SB: The many faces of lung adenocarcinoma: A pictorial essay. J Med
Imaging Radiat Oncol. 62:654–661. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li Y, Yu WK, Chen L, Chan YS, Liu D, Fong
CC, Xu T, Zhu G, Sun D and Yang M: Electrotaxis of tumor-initiating
cells of H1975 lung adenocarcinoma cells is associated with both
activation of stretch-activated cation channels (SACCs) and
internal calcium release. Bioelectrochemistry. 124:80–92. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Déliot N and Constantin B: Plasma membrane
calcium channels in cancer: Alterations and consequences for cell
proliferation and migration. Biochim Biophys Acta. 1848:2512–2522.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fan H, Shen YX and Yuan YF: Expression and
Prognostic Roles of TRPV5 and TRPV6 in Non-small cell lung cancer
after curative resection. Asian Pac J Cancer Prev. 6:2559–2563.
2014. View Article : Google Scholar
|
|
14
|
Ma X, Cai Y, He D, Zou C, Zhang P, Lo CY,
Xu Z, Chan FL, Yu S, Chen Y, et al: Transient receptor potential
channel TRPC5 is essential for P-glycoprotein induction in
drug-resistant cancer cells. Proc Natl Acad Sci USA.
109:16282–16287. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Capiod T: Extracellular calcium has
multiple targets to control cell proliferation. Adv Exp Med Biol.
898:133–156. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang LL, Liu BC, Lu XY, Yan Y, Zhai YJ,
Bao Q, Doetsch PW, Deng X, Thai TL, Alli AA, et al: Inhibition of
TRPC6 reduces non-small cell lung cancer cell proliferation and
invasion. Oncotarget. 8:5123–5134. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Racioppi L, Nelson ER, Huang W, Mukherjee
D, Lawrence SA, Lento W, Masci AM, Jiao Y, Park S, Liu Y, et al:
CaMKK2 in myeloid cells is a key regulator of the
immune-suppressive microenvironment in breast cancer. Nat Commun.
10:24502019. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Vaz CV, Rodrigues DB, Socorro S and Maia
CJ: Effect of Extracellular calcium on regucalcin expression and
cell viability in neoplastic and non-neoplastic human prostate
cells. Biochim Biophys Acta. 1853:2621–2628. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Yuan K, Chung LW, Siegal GP and Zayzafoon
M: Alpha-CaMKII controls the growth of human osteosarcoma by
regulating cell cycle progression. Lab Invest. 87:938–950. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Byun JS, Sohn JM, Leem DG, Park B, Nam JH,
Shin DH, Shin JS, Kim HJ, Lee KT and Lee JY: In vitro synergistic
anticancer activity of the combination of T-type calcium channel
blocker and chemotherapeutic agent in A549 cells. Bioorg Med Chem
Lett. 26:1073–1079. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
He Y, Lin G, Han D, Shi D, Liu T, Gao Y,
Guan W and Cheng G: Aclidinium Bromide holds promising inhibitory
effects in A549 lung cancer cells potentials by regulating PI3K/AKT
signaling pathway. J BUON. 24:560–565. 2019.PubMed/NCBI
|
|
22
|
Vervliet T, Parys JB and Bultynck G: Bcl-2
proteins and calcium signaling: Complexity beneath the surface.
Oncogene. 35:5079–5092. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Annunziato L, Amoroso S, Pannaccione A,
Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud
L and Di Renzo GF: Apoptosis induced in neuronal cells by oxidative
stress: Role played by caspases and intracellular calcium ions.
Toxicol Lett. 139:125–133. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li G, He Y, Yao J, Huang C, Song X, Deng
Y, Xie S, Ren J, Jin M and Liu H: Angelicin inhibits human lung
carcinoma A549 cell growth and migration through regulating JNK and
ERK pathways. Oncol Rep. 36:3504–3512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lin X, Li HR, Lin XF, Yu ME, Tu XW, Hua
ZD, Lin M, Xu NL, Han LL and Chen YS: Silencing of Livin inhibits
tumorigenesis and metastasis via VEGF and MMPs pathway in lung
cancer. Int J Oncol. 47:657–667. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Shi S, Luo W, Zhang R, Wang C, Zheng Y,
Song Y, Wang R, Zhang L, Zhang L, Li W and Luo Z: CRTC2 promotes
non-small cell lung cancer A549 migration and invasion in vitro.
Thorac Cancer. 9:136–141. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pastushenko I and Blanpain C: EMT
Transition states during tumor progression and metastasis. Trends
Cell Biol. 29:212–226. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Daugaard I, Sanders KJ, Idica A,
Vittayarukskul K, Hamdorf M, Krog JD, Chow R, Jury D, Hansen LL,
Hager H, et al: MiR-151a induces partial EMT by regulating
E-cadherin in NSCLC cells. Oncogenesis. 6:e3662017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Gloushankova NA, Rubtsova SN and Zhitnyak
IY: Cadherin-mediated cell-cell interactions in normal and cancer
cells. Tissue Barriers. 5:e13569002017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Tadokoro A, Kanaji N, Liu D, Yokomise H,
Haba R, Ishii T, Takagi T, Watanabe N, Kita N, Kadowaki N and
Bandoh S: Vimentin regulates invasiveness and is a poor prognostic
marker in non-small cell lung cancer. Anticancer Res. 36:1545–1551.
2016.PubMed/NCBI
|
|
31
|
Sun Z, Zhang H, Wang X, Wang QC, Zhang C,
Wang JQ, Wang YH, An CQ, Yang KY, Wang Y, et al: TMCO1 is essential
for ovarian follicle development by regulating ER Ca 2+
Store of Granulosa cells. Cell Death Differ. 9:1686–1701. 2018.
View Article : Google Scholar
|
|
32
|
Alanay Y, Ergüner B, Utine E, Haçariz O,
Kiper PO, Taşkıran EZ, Perçin F, Uz E, Sağiroğlu MŞ, Yuksel B, et
al: TMCO1 Deficiency causes autosomal recessive
cerebrofaciothoracic dysplasia. Am J Med Genet A. 164:291–304.
2014. View Article : Google Scholar
|
